NCT00448669View on ClinicalTrials.gov

Botswana TDF/FTC Oral HIV Prophylaxis Trial

PHASE2/PHASE3CompletedINTERVENTIONAL

Enrollment

1,219

Participants

Timeline

Start Date

March 31, 2007

Primary Completion Date

March 31, 2011

Study Completion Date

March 31, 2011

Conditions

HIV Infections

Interventions

DRUG

Tenofovir Disoproxil Fumarate 300 mg + Emtricitabine 200 mg

DRUG

Placebo Oral Tablet

Trial Locations (2)

30333

Centers for Disease Control and Prevention, Atlanta

Unknown

BOTUSA HIV Prevention Research Unit, Gaborone

Sponsors

Collaborators (1)

Gilead Sciences

All Listed Sponsors

collaborator

Botswana Ministry of Health

OTHER_GOV

collaborator

Gilead Sciences

INDUSTRY

lead

Centers for Disease Control and Prevention

FED